Finance

Lists
Why is SBS down 2,92%?
Dive Deeper
SBS:FRA
Stratec SE
21,60 €
-2,92%
(-0,65) 1D
9 қаз., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
21,60 €
High
21,60 €
Low
21,60 €
Mkt. cap
259,33 млн
Avg. vol.
51,00
Volume
0,00
Dividend
2,78%
Quarterly dividend
0,15 €
Ex-dividend date
2026 ж. 24 мау.
52-wk high
30,05 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 млн
No. of employees
1 мың
Open
21,60 €
High
21,60 €
Low
21,60 €
Mkt. cap
259,33 млн
Avg. vol.
51,00
Volume
0,00
Dividend
2,78%
Quarterly dividend
0,15 €
Ex-dividend date
2026 ж. 24 мау.
52-wk high
30,05 €
52-wk low
16,38 €
EPS
-0,03 €
Shares outstanding
11,96 млн
No. of employees
1 мың
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1,38 мың
Founded1979
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
57,00 млн
75,28 млн
53,43 млн
59,11 млн
Cost of goods sold
43,70 млн
56,31 млн
43,22 млн
43,87 млн
Cost of revenue
43,70 млн
56,31 млн
43,22 млн
43,87 млн
Research and development expenses
1,59 млн
2,78 млн
1,72 млн
1,49 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,47 млн
10,82 млн
8,82 млн
9,64 млн
Operating expense
9,78 млн
11,19 млн
10,30 млн
9,66 млн
Total operating expenses
53,48 млн
67,50 млн
53,53 млн
53,54 млн
Operating income
3,52 млн
7,78 млн
-104,00 м.
5,57 млн
Other non operating income
-117,00 м.
219,00 м.
-65,00 мың
61,00 мың
EBT including unusual items
2,38 млн
-826,00 м.
-1,16 млн
5,43 млн
EBT excluding unusual items
2,38 млн
5,55 млн
-1,16 млн
5,43 млн
Income tax expense
878,00 м.
3,52 млн
557,00 м.
1,27 млн
Effective tax rate
36,91%
-426,03%
-48,18%
23,35%
Other operating expenses
-274,00 м.
-2,41 млн
-235,00 м.
-1,46 млн
Net income
1,50 млн
-4,34 млн
-1,71 млн
4,16 млн
Net profit margin
2,63%
-5,77%
-3,21%
7,04%
Earnings per share
-
-
-
-
Interest and investment income
33,00 мың
8,00 мың
34,00 мың
55,00 мың
Interest expense
-1,06 млн
-955,00 м.
-1,02 млн
-260,00 м.
Net interest expenses
-1,02 млн
-947,00 м.
-987,00 м.
-205,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
8,04 млн
10,71 млн
4,45 млн
10,03 млн
Gain or loss from assets sale
13,00 мың
3,00 мың
-94,00 мың
-9,00 мың
AI content may include mistakes. Learn more
Google қолданбалары